-transparent.png){kind=logo}
In massive blood loss (1000-4900 ml) during operations on the kidneys, urinary tract and prostate in 65 patients 750 to 3600 ml of blood were reinfused. Sixty (92.3%) patients recovered. Fatal outcomes in 5 cases were caused by complications of the underlying and concomitant diseases and were unrelated to blood reinfusion. Study of morphological, biochemical and coagulation properties of the patients' blood showed gradual restoration of hemostatic values and the absence of harmful effect of the reinfusion on the organism. The authors claim that blood reinfusion can be undertaken in operations on the kidney, urinary tract and prostate when there are vital indications. Kidney tumors are a relative contraindication for reinfusion. Blood reinfusion is not indicated in purulent diseases of the kidneys.
E A Vagner, and
M I Davidov
January 1979,
International urology and nephrology,
E A Vagner, and
M I Davidov
January 1984,
Grudnaia khirurgiia (Moscow, Russia),
E A Vagner, and
M I Davidov
July 1991,
Khirurgiia,
E A Vagner, and
M I Davidov
January 1987,
Klinicheskaia khirurgiia,
E A Vagner, and
M I Davidov
June 1952,
Journal of the American Medical Association,
E A Vagner, and
M I Davidov
May 1953,
Journal of the Indian Medical Association,
E A Vagner, and
M I Davidov
January 1982,
Fel'dsher i akusherka,
E A Vagner, and
M I Davidov
August 1987,
Vestnik khirurgii imeni I. I. Grekova,
E A Vagner, and
M I Davidov
June 1963,
Minerva cardioangiologica,
E A Vagner, and
M I Davidov
June 1982,
Vestnik khirurgii imeni I. I. Grekova,
